Ranbaxy receives Australian OK for terbinafine
This article was originally published in Scrip
Executive Summary
Ranbaxy Laboratories has received approval from Australia's Therapeutic Goods Administration for the registration of Sebifin terbinafine tablets, a generic version of Novartis's antifungal, Lamisil tablets. The marketing authorisation application was submitted by Ranbaxy's Australian subsidiary.